DRI and Foundation News

Press Releases     In the News     DRI tv     Publications     images & Video     D-Stats       

Images


We are pleased to provide the following images to members of diabetes community and the media covering the DRI. Please click on a thumbnail below to download a lo-res image. For additional images or inquiries, please contact us.

Engineering a Biological Scaffold for a DRI BioHub Platform
Engineering a Biological Scaffold onto the Omentum for a DRI BioHub Platform

DRI Director Camillo Ricordi, M.D.
Camillo Ricordi, M.D., Director of the Diabetes Research Institute

Camillo Ricordi, M.D, holds the Ricordi Chamber
DRI Director Camillo Ricordi, M.D., holds the Ricordi Chamber

Alice Tomei, Ph.D., Director of Immunoengineering
Alice Tomei, Ph.D., Director of the DRI's Immunoengineering Lab

Members of the DRI's multidisciplinary research team
Clinical trial meeting among DRI's multidisciplinary research team

Inside the DRI's cGMP facility
Inside the DRI's cGMP human cell processing facility

Peter Buchwald, Ph.D.
Peter Buchwald, Ph.D., Director of Drug Discovery

Armando Mendez, Ph.D., director of the DRI's Biomarker and Immunoassay Core Laboratory
Armando Mendez, Ph.D., Director of the Biomarker and Immunoassay Lab

The multi-center NIH-sponsored Type 1 Diabetes TrialNet is housed at the Diabetes Research Institute
Lisa Rafkin-Mervis and Della Matheson are part of the DRI's TrialNet team

Islet Isolation and Transplantation_Intrahepatic
Islet Isolation and Transplantation Graphic (liver)

Islet cells in petri dish
Isolated human pancreatic islet cells in petri dish

Rodolfo Alejandro, M.D., and David Baidal, M.D.
Rodolfo Alejandro, M.D., and David Baidal, M.D., clinical islet transplant

Drs. Allison Bayer and Chris Fraker
Allison Bayer, Ph.D., and Chris Fraker, Ph.D.

Alberto Pugliese, M.D., Dodson Chair in Diabetes Research and Deputy Director of Immune Tolerance
Alberto Pugliese, M.D., Deputy Director for Immune Tolerance

Alberto Pugliese, M.D., Thomas Malek, Ph.D.
Alberto Pugliese, M.D., and Thomas Malek, Ph.D.

Thumbnail_Diabetes Research Institute Clinical Cell Transplant Team
Diabetes Research Institute Clinical Cell Transplant Team

Drs. Norma S. Kenyon and Dora Berman-Weinberg (at scope)
Dora Berman-Weinberg, Ph.D., and Norma S. Kenyon Ph.D.

Ronald B. Goldberg, M.D., and the Diabetes Prevention Program team
Ronald B. Goldberg, M.D., with the Diabetes Prevention Program team

Diabetes Research Institute, University of Miami Miller School of Medicine
Diabetes Research Institute, University of Miami Miller School of Medicine

Jay Skyler, M.D., Deputy Director of Clinical Research and Academic Programs
Jay Skyler, M.D., Deputy Dir., Clinical Research and Academic Programs

Peter Buchwald, Ph.D., with representatives from Biorep
Peter Buchwald, Ph.D., with members of Biorep Technologies

Observing islets through the Living Window
Observing transplanted islets through the "Living Window" eye model

Diana Velluto, Ph.D., polymer chemist
Chemists enhance DRI's conformal coatings with nanotechnologies

DRI's Juan Dominguez-Bendala, Ph.D., and Ricardo Pastori, Ph.D., of the DRI's Cell Supply Team.
Juan Dominguez-Bendala, Ph.D., and Ricardo Pastori, Ph.D., Cell Supply

Diego Correa, M.D., Ph.D., is an expert in mesenchymal stem cells.
Diego Correa, M.D., Ph.D., is an expert in mesenchymal stem cells

Ernesto Bernal-Mizrachi MD_Deputy Director of Beta Cell Biology and Signal Transduction
Ernesto Bernal-Mizrachi, M.D., Deputy Director for Beta Cell Biology

Luis Roque and Khemraj "Raj" Hirani, Ph.D.
Luis Roque and Khemraj Hirani, Ph.D., of DRI's Regulatory Affairs Team

Video




The BioHub strategy can best be grouped into three avenues of research that are simultaneously being pursued by the DRI: engineering a mini endocrine pancreas within the body, protecting the islets from immune system attack, and identifying an unlimited source of insulin-producing cells to treat the millions living with diabetes.

 



A #T1DSuperhero might not be able to leap tall buildings in a single bound, but those with type 1 diabetes take heroic actions every single day to conquer the challenges of living with this disease. The Diabetes Research Institute Foundation pays tribute to all T1D superheroes, with this public service announcement that likens them -- and the DRI scientists who are working to find a cure -- to real superheroes.



Ron Darling, named one of the 50 Greatest Mets of all time by Newsday (July 2012), is an Emmy-winning sports analyst and a member of the DRI Foundation's National Board of Directors. He will stop at nothing until a cure is found for his eldest son, Jordan, who was diagnosed with type 1 diabetes at age 11.

Keep up with our progress toward a cure & more

Be a DRI Insider - Get News!

Media Contacts:

Lauren Schreier
Sr. Director, Marketing & Comm
954.964.4040

Nicole Lesson
Communications Manager
954.964.4040

Joelle Parra
Comm & Social Media Manager
954.964.4040

Mitra Zehtab, MD, MBA
COO 
305.243.9537